BNP Paribas Financial Markets’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $721K | Sell |
9,611
-34,424
| -78% | -$2.21M | ﹤0.01% | 3540 |
|
|
2026
Q1 | $2.48M | Sell |
44,035
-23,975
| -35% | -$1.56M | ﹤0.01% | 2533 |
|
|
2025
Q4 | $5.45M | Buy |
68,010
+51,658
| +316% | +$3.47M | ﹤0.01% | 1985 |
|
|
2025
Q3 | $797K | Buy |
16,352
+321
| +2% | +$19.9K | ﹤0.01% | 3280 |
|
|
2025
Q2 | $1.2M | Sell |
16,031
-2,169
| -12% | -$144K | ﹤0.01% | 2801 |
|
|
2025
Q1 | $1.16M | Sell |
18,200
-15,009
| -45% | -$1.02M | ﹤0.01% | 2677 |
|
|
2024
Q4 | $2.59M | Buy |
33,209
+16,260
| +96% | +$1.31M | ﹤0.01% | 2216 |
|
|
2024
Q3 | $1.36M | Buy |
16,949
+10,774
| +174% | +$870K | ﹤0.01% | 2297 |
|
|
2024
Q2 | $511K | Sell |
6,175
-22,796
| -79% | -$2.01M | ﹤0.01% | 2655 |
|
|
2024
Q1 | $2.47M | Buy |
28,971
+1,874
| +7% | +$147K | ﹤0.01% | 1925 |
|
|
2023
Q4 | $2.32M | Sell |
27,097
-6,485
| -19% | -$561K | ﹤0.01% | 1867 |
|
|
2023
Q3 | $3.01M | Buy |
33,582
+20,112
| +149% | +$1.8M | ﹤0.01% | 1622 |
|
|
2023
Q2 | $1.15M | Sell |
13,470
-8,604
| -39% | -$727K | ﹤0.01% | 2109 |
|
|
2023
Q1 | $1.83M | Buy |
22,074
+14,148
| +179% | +$1.15M | ﹤0.01% | 1889 |
|
|
2022
Q4 | $623K | Sell |
7,926
-9,574
| -55% | -$770K | ﹤0.01% | 2443 |
|
|
2022
Q3 | $1.3M | Buy |
17,500
+5,071
| +41% | +$364K | ﹤0.01% | 2282 |
|
|
2022
Q2 | $810K | Sell |
12,429
-23,696
| -66% | -$1.4M | ﹤0.01% | 2350 |
|
|
2022
Q1 | $2.28M | Sell |
36,125
-43,622
| -55% | -$2.37M | ﹤0.01% | 1733 |
|
|
2021
Q4 | $4.23M | Buy |
79,747
+70,113
| +728% | +$4.27M | 0.01% | 1464 |
|
|
2021
Q3 | $680K | Buy |
9,634
+2,738
| +40% | +$173K | ﹤0.01% | 2602 |
|
|
2021
Q2 | $460K | Sell |
6,896
-52,843
| -88% | -$3.74M | ﹤0.01% | 2568 |
|
|
2021
Q1 | $6.63M | Buy |
59,739
+50,829
| +570% | +$6.29M | 0.01% | 1014 |
|
|
2020
Q4 | $1.06M | Sell |
8,910
-13,492
| -60% | -$1.45M | ﹤0.01% | 1991 |
|
|
2020
Q3 | $1.95M | Sell |
22,402
-86,198
| -79% | -$7.53M | ﹤0.01% | 1536 |
|
|
2020
Q2 | $9.73M | Buy |
108,600
+99,860
| +1,143% | +$10.1M | 0.02% | 714 |
|
|
2020
Q1 | $871K | Sell |
8,740
-23,997
| -73% | -$2.6M | ﹤0.01% | 2009 |
|
|
2019
Q4 | $3.76M | Buy |
32,737
+22,652
| +225% | +$2.74M | 0.01% | 1352 |
|
|
2019
Q3 | $1.27M | Buy |
10,085
+3,987
| +65% | +$506K | ﹤0.01% | 1729 |
|
|
2019
Q2 | $734K | Sell |
6,098
-4,971
| -45% | -$489K | ﹤0.01% | 1842 |
|
|
2019
Q1 | $968K | Buy |
11,069
+10,192
| +1,162% | +$927K | ﹤0.01% | 1713 |
|
|
2018
Q4 | $87.7K | Sell |
877
-5,361
| -86% | -$563K | ﹤0.01% | 2425 |
|
|
2018
Q3 | $715K | Sell |
6,238
-100,250
| -94% | -$10.4M | ﹤0.01% | 1876 |
|
|
2018
Q2 | $9.55M | Buy |
106,488
+89,082
| +512% | +$7.52M | 0.02% | 818 |
|
|
2018
Q1 | $1.27M | Sell |
17,406
-4,583
| -21% | -$314K | ﹤0.01% | 1585 |
|
|
2017
Q4 | $1.28M | Sell |
21,989
-5,614
| -20% | -$296K | ﹤0.01% | 1795 |
|
|
2017
Q3 | $1.24M | Buy |
27,603
+9,607
| +53% | +$399K | ﹤0.01% | 1427 |
|
|
2017
Q2 | $711K | Buy |
17,996
+7,009
| +64% | +$288K | ﹤0.01% | 1713 |
|
|
2017
Q1 | $446K | Sell |
10,987
-22
| -0.2% | -$859 | ﹤0.01% | 1809 |
|
|
2016
Q4 | $443K | Buy |
11,009
+2,521
| +30% | +$95.1K | ﹤0.01% | 1761 |
|
|
2016
Q3 | $307K | Sell |
8,488
-8,095
| -49% | -$278K | ﹤0.01% | 1500 |
|
|
2016
Q2 | $481K | Buy |
16,583
+8,540
| +106% | +$258K | ﹤0.01% | 1528 |
|
|
2016
Q1 | $281K | Buy |
8,043
+1,832
| +29% | +$59.2K | ﹤0.01% | 1406 |
|
|
2015
Q4 | $200K | Sell |
6,211
-5,115
| -45% | -$166K | ﹤0.01% | 1481 |
|
|
2015
Q3 | $366K | Buy |
11,326
+6,689
| +144% | +$252K | ﹤0.01% | 1536 |
|
|
2015
Q2 | $192K | Buy |
4,637
+3,396
| +274% | +$143K | ﹤0.01% | 1730 |
|
|
2015
Q1 | $55.7K | Buy |
+1,241
| New | +$51.9K | ﹤0.01% | 1893 |
|
|
2014
Q4 | – | Sell |
-3,111
| Closed | -$109K | – | 2504 |
|
|
2014
Q3 | $109K | Buy |
3,111
+3,008
| +2,920% | +$107K | ﹤0.01% | 2137 |
|
|
2014
Q2 | $3.63K | Buy |
103
+61
| +145% | +$2.04K | ﹤0.01% | 2771 |
|
|
2014
Q1 | $1.27K | Sell |
42
-620
| -94% | -$23.7K | ﹤0.01% | 2789 |
|
|
2013
Q4 | $27.9K | Sell |
662
-13,411
| -95% | -$552K | ﹤0.01% | 2109 |
|
|
2013
Q3 | $561K | Sell |
14,073
-3,729
| -21% | -$156K | ﹤0.01% | 1466 |
|
|
2013
Q2 | $736K | Buy |
+17,802
| New | +$721K | ﹤0.01% | 1234 |
|
Other funds holding HAE
AI
BNP Paribas Financial Markets's HAE Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Haemonetics (HAE) stake by 78% in Q2 2026, selling an estimated $2.21M and leaving 9,611 shares worth $721K. The position accounts for ﹤0.01% of the portfolio, ranked #3540.
BNP Paribas Financial Markets first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.73M in Q2 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- BNP Paribas Financial Markets held 9,611 shares of Haemonetics worth $721K as of Q2 2026.
- BNP Paribas Financial Markets sold 34,424 Haemonetics shares in Q2 2026, an estimated $2.21M.
- Haemonetics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3540 holding.
- BNP Paribas Financial Markets first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Financial Markets's Haemonetics position peaked at $9.73M in Q2 2020.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.